QGEN Working Capital Per Revenue	(Dec 31 2024) IV. Quarter	0 III. Quarter	0 II. Quarter	0 I. Quarter	(Dec 31 2023) IV. Quarter
Y / Y Working Capital Change	23.56 %	23.56 %	23.56 %	23.56 %	-22.58 %
Y / Y Revenue Change	0.98 %	-	-	-	-8.67 %
Working Capital Per Revenue	0.95	0.91	0.87	0.82	0.78
Working Capital Per Revenue Ranking	# 2391	# 0	# 0	# 2587	#
Seq. Working Capital Change	0 %	0 %	0 %	23.56 %	0 %
Seq. Revenue Change	-	-	-	-	-

New: More QGEN's historic Working Capital Per Revenue Ratios >>

Financial strength information for the Healthcare sector >> Back to QGEN Financial Strength Comparisons >> See QGEN Balance Sheets

Comment on QGEN's Working Capital Per Revenue in the fourth quarter 2024

Qiagen N V 's Working Capital Per Revenue sequentially grew to 0.95 during the Q4 2024, above the company average.

Within Healthcare sector 57 other companies have achieved lower Working Capital Per Revenue during the Q4 2024. While Working Capital Per Revenue total ranking has deteriorated in the fourth quarter 2024, compared to previous quarter from 0 to 2391.

Working Capital Per Revenue Ranking
Within:	No.
Industry	# 10
Sector	# 58
S&P 500	# 2391

Working Capital Per Revenue Statistics
High	Average	Low
0.93	0.61	0.2
(Dec 31 2017)		(Dec 31 2021)

Financial Statements
Qiagen N V 's Working Capital	$ 1,823 Millions	Visit QGEN's Balance sheet
Qiagen N V 's Revenues	$ 1,919 Millions	Visit QGEN's Income Statement
Where are QGEN's Sales coming from?		Visit QGEN's Sales by Geography

Companies with similar Average Working Capital Per Revenue for 12 months ending Dec 31 2024, within Healthcare Sector	Working Capital Per Revenue
Capricor Therapeutics inc	2.59
Xenetic Biosciences Inc	2.58
Urogen Pharma Ltd	2.53
Mersana Therapeutics Inc	2.52
Utah Medical Products Inc	2.51
Dyadic International Inc	2.49
Immunocore Holdings Plc	2.42
Quanterix Corporation	2.41
Assembly Biosciences Inc	2.40
Nektar Therapeutics	2.35
Meiragtx Holdings Plc	2.31
Ionis Pharmaceuticals Inc	2.30
Bridgebio Pharma Inc	2.25
Retractable Technologies Inc	2.16
Moderna Inc	2.15
Scpharmaceuticals Inc	2.15
Iovance Biotherapeutics inc	2.14
Outset Medical Inc	2.14
Maravai Lifesciences Holdings Inc	2.14
Krystal Biotech Inc	2.09
Omniab Inc	2.06
Standard Biotools Inc	2.04
Cue Biopharma Inc	2.04
Cvrx inc	2.01
Agape Atp Corporation	1.99
Amarin Corp Plcuk	1.97
Butterfly Network Inc	1.94
Zevra Therapeutics Inc	1.91
Rhythm Pharmaceuticals inc	1.89
Pacific Health Care Organization Inc	1.85

Date modified: 2025-04-02T03:30:06+00:00

Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com